BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
BioAdaptives's operating income for the twelve months ending Jun 30, 2026 was -$909.20K. For fiscal 2025 it was -$1.04M. The highest annual figure on record is -$227.28K in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.04M | – |
| FY2024 | Dec 31, 2024 | -$602.09K | – |
| FY2023 | Dec 31, 2023 | -$228.92K | – |
| FY2022 | Dec 31, 2022 | -$421.90K | – |
| FY2015 | Dec 31, 2015 | -$227.28K | – |
| FY2014 | Dec 31, 2014 | -$2.44M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$197.18K | – |
| Q1 FY2026 | Mar 31, 2026 | -$198.22K | – |
| Q4 FY2025 | Dec 31, 2025 | -$248.12K | – |
| Q3 FY2025 | Sep 30, 2025 | -$265.69K | – |
| Q2 FY2025 | Jun 30, 2025 | -$279.22K | – |
| Q1 FY2025 | Mar 31, 2025 | -$249.15K | – |
| Q4 FY2024 | Dec 31, 2024 | -$337.34K | – |
| Q3 FY2024 | Sep 30, 2024 | -$121.94K | – |
| Q2 FY2024 | Jun 30, 2024 | -$92.98K | – |
| Q1 FY2024 | Mar 31, 2024 | -$49.83K | – |
| Q4 FY2023 | Dec 31, 2023 | -$61.78K | – |
| Q3 FY2023 | Sep 30, 2023 | -$92.21K | – |
| Q2 FY2023 | Jun 30, 2023 | -$55.95K | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.98K | – |
| Q3 FY2016 | Sep 30, 2016 | -$26.31K | – |
| Q2 FY2016 | Jun 30, 2016 | -$33.21K | – |
| Q1 FY2016 | Mar 31, 2016 | -$80.92K | – |
| Q4 FY2015 | Dec 31, 2015 | -$48.51K | – |
| Q3 FY2015 | Sep 30, 2015 | -$40.14K | – |
See a number that looks wrong?